| For: | Zhou MH, Ye MF, Zhang ZX, Tao F, Zhang Y. Cytokine release syndrome triggered by programmed death 1 blockade (sintilimab) therapy in a psoriasis patient: A case report. World J Clin Cases 2024; 12(18): 3555-3560 [PMID: 38983424 DOI: 10.12998/wjcc.v12.i18.3555] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v12/i18/3555.htm |
| Number | Citing Articles |
| 1 |
Qiong Jin, Qinglei Fu, Bifeng Fei. Immune checkpoint inhibitors-related cytokine storm syndrome: a systematic review of characteristics, treatment, and outcomes. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1860219
|
| 2 |
Po-Chin Chao, Akiko Karakawa, Masahiro Hosonuma, Yuki Azetsu, Shogo Kamikawa, Aoi Oshio, Masahiro Chatani, Tatsuo Shirota, Masamichi Takami. Effects of anti-RANKL and anti-PD-1 antibodies on cancer-induced osteolysis in mice. Journal of Oral Biosciences 2025; 67(3) doi: 10.1016/j.job.2025.100682
|
| 3 |
Mahesh Kumar Posa, Jyoti Singh, Sadia Parveen, Subhranshu Panda. CAR T- cell therapy: A promising novel approach for treatment of cancer. Cancer Treatment and Research Communications 2026; 47 doi: 10.1016/j.ctarc.2026.101125
|
| 4 |
Ming Li, Chen Li, Zhi-Min Lin, Yu-Wei Wang, Di Jin. Medical dilemma: Programmed death 1 blockade (sintilimab) therapy in patients suffering from tumours combined with psoriasis. World Journal of Cardiology 2024; 16(9): 546-549 doi: 10.4330/wjc.v16.i9.546
|
| 5 |
Saurabh Upadhyay, Kirti Upmanyu, Moustafa T. Gabr. Designing immunity with cytokines: A logic-based framework for programmable CAR therapies. Cytokine & Growth Factor Reviews 2025; 86 doi: 10.1016/j.cytogfr.2025.09.004
|
| 6 |
|
| 7 |
Lenin Pavón, Ana Fragozo, José Luis Maldonado-García. Cytokine release syndrome induced by anti-programmed death-1 treatment in a psoriasis patient: A dark side of immune checkpoint inhibitors. World Journal of Clinical Cases 2024; 12(35): 6782-6790 doi: 10.12998/wjcc.v12.i35.6782
|